CISAPRIDE MONOHYDRATE powder

País: Estados Unidos

Língua: inglês

Origem: NLM (National Library of Medicine)

Compre agora

Ingredientes ativos:

CISAPRIDE MONOHYDRATE (UNII: VZV0A4I38W) (CISAPRIDE - UNII:UVL329170W)

Disponível em:

AX Pharmaceutical Corp

Via de administração:

NOT APPLICABLE

Status de autorização:

Bulk Ingredient For Animal Drug Compounding

Características técnicas

                                CISAPRIDE MONOHYDRATE- CISAPRIDE MONOHYDRATE POWDER
AX PHARMACEUTICAL CORP
----------
PRODUCT LABEL
CISAPRIDE MONOHYDRATE
cisapride monohydrate powder
PRODUCT INFORMATION
PRODUCT T YPE
BULK INGREDIENT
ITE M CODE (SOURCE )
NDC:6 2157-744
ROUTE OF ADMINISTRATION
NOT APPLICABLE
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH
STRE NG TH
CISAPRIDE MO NO HYDRATE (UNII: VZV0 A4I38 W) (CISAPRIDE - UNII:UVL329
170 W)
CISAPRIDE MONOHYDRATE
25 g in 25 g
PACKAG ING
#
ITEM CODE
PACKAGE DESCRIPTION
MARKETING START DATE
MARKETING END DATE
1
NDC:6 2157-744-0 1
25 g in 1 JAR
12/13/20 18
MARKETING INFORMATION
MARKE TING CATE GORY
APPLICATION NUMBE R OR MONOGRAPH
CITA TIO N
MARKE TING START
DATE
MARKE TING END
DATE
bulk ingredient fo r animal drug
c o mpo unding
12/13/20 18
AX Pharmaceutical Corp
LABELER -
AX Pharmaceutical Corp (202924858)
ESTABLISHMENT
NAME
AD D RE S S
ID/FEI
BUSINE SS OPE RATIONS
Nanjing Chemlin Bio medical Science & Techno lo gy Co , Ltd.
421371710
ma nufa c ture (6 2157-744)
Revised: 12/2018
                                
                                Leia o documento completo
                                
                            

Pesquisar alertas relacionados a este produto